Sanofi-aventis Forms Covalent Drug Discovery Partnership with Avila Therapeutics in Oncology
By Heather Cartwright
Pharma Deals Review: Vol 2011 Issue 1 (Table of Contents)
Published: 14 Jan-2011
DOI: 10.3833/pdr.v2011.i1.1420 ISSN: 1756-7874
Section: Joint Venture
Fulltext:
Abstract
Sanofi-aventis has signed a global strategic alliance with Avila Therapeutics that is worth more than US$800 M, including US$40 M upfront and as much as US$770 M in milestone payments...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018